Cor Vasa 2016, 58(5):e497-e500 | DOI: 10.1016/j.crvasa.2016.04.004
Methadone-related QT prolongation and arrhythmic storm in an addicted patient: What weapons to use in a lost war?
- Department of Clinical and Experimental Medicine, University Hospital of Messina, Messina, Italy
Drug-induced QT prolongation is a common finding in patients on therapy with antidepressants, antipsychotic, diuretics, antiarrhytmic drugs, etc. Drug's interruption normally restored QT interval. A 50-year-old man, with a history of abuse of heroin in treatment with methadone, was admitted in our department for syncope. He made occasional abuse of cocaine. On the day before he had vomited and diarrhea. The electrocardiogram showed sinus bradycardia and a prolonged corrected QT interval. Serum potassium levels resulted quite low. During the ECG monitoring, multiple torsade de pointes degenerating in ventricular fibrillation with loss of consciousness occurred (treated with prompt DC-shock). Infusion of isoproterenol was undertaken resulting in suppression of ventricular arrhythmias. Considering the possibility of failure of opioid's replacement and the unknown genetic substrate of the QT prolongation, ICD implantation was performed. Management of patients with methadone-related QT prolongation is not simple, mainly due to difficulty in replacing or sudden interruption of this drug. Isoproterenol infusion is a good choice in the acute setting. In the long term, ICD is probably an appropriate therapy in order to prevent sudden death in this particular population. Frequent ECG monitoring is useful to prevent QT prolongation and arrhythmic risk in patients treated with methadone.
Keywords: Arrhythmic storm; Drug abuse; Loss of consciousness; Methadone; QT prolongation
Received: March 7, 2016; Accepted: April 14, 2016; Published: October 1, 2016 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- S. Mujtaba, J. Romero, C.C. Taub, Methadone, QTc prolongation and torsades de pointes: current concepts, management and a hidden twist in the tale?, Journal of Cardiovascular Disease Research 4 (2013) 229-235.
Go to original source...
Go to PubMed...
- M.J. Krantz, W.A. Baker, J. Schmittner, Cocaine and methadone: parallel effects on the QTc interval, American Journal of Cardiology 98 (2006) 1121.
Go to original source...
Go to PubMed...
- I.M. de Jong, G.S. de Ruiter, Buprenorphine as a safe alternative to methadone in a patient with acquired long QT syndrome: a case report, Netherlands Heart Journal 21 (2013) 249-252.
Go to original source...
Go to PubMed...
- S. Mayet, M. Gossop, N. Lintzeris, et al., Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?, Drug and Alcohol Review 30 (2011) 388-396.
Go to original source...
Go to PubMed...
- A.M. Patel, J.P. Singh, J.N. Ruskin, Role of implantable cardioverter-defibrillators in patients with methadone-induced long QT syndrome, American Journal of Cardiology 101 (2008) 209-211.
Go to original source...
Go to PubMed...
- M.A. Miller, K. Bhasin, V.Y. Reddy, A. d'Avila, Left cardiac sympathetic denervation for the treatment of methadone-induced long QT syndrome, Heart Rhythm 8 (2011) 1955-1957.
Go to original source...
Go to PubMed...